Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CEVA ANIMAL HEALTH A/S

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1%   Bankruptcy risk   0.7% 2.3% 2.3% 2.2% 0.7% 0.5% 5.7% 5.1%   Credit score (0-100)   94 66 65 63 95 98 15 17   Credit rating   A BBB BBB BBB A A BB BB   Credit limit (kDKK)   1,703.2 0.4 0.7 1.0 5,487.1 7,148.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   20,794 26,431 29,490 35,966 32,067 37,946 0.0 0.0   EBITDA   4,597 26,431 29,490 35,966 12,658 13,279 0.0 0.0   EBIT   2,661 26,431 29,490 35,966 11,276 11,774 0.0 0.0   Pre-tax profit (PTP)   1,938.0 2,376.0 4,194.0 6,782.0 9,905.0 10,877.0 0.0 0.0   Net earnings   1,414.0 2,376.0 4,194.0 6,782.0 7,658.0 8,351.0 0.0 0.0   Pre-tax profit without non-rec. items   1,938 26,431 29,490 35,966 9,905 10,877 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 767 596 0.0 0.0   Shareholders equity total   8,854 11,229 15,423 22,205 29,863 38,214 37,714 37,714   Interest-bearing liabilities   27,328 0.0 0.0 0.0 56,837 53,051 0.0 0.0   Balance sheet total (assets)   47,566 79,985 86,203 100,642 101,327 111,000 37,714 37,714   Net Debt   17,583 0.0 0.0 0.0 21,852 8,613 -33,699 -33,699     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   20,794 26,431 29,490 35,966 32,067 37,946 0.0 0.0   Gross profit growth   23.3% 27.1% 11.6% 22.0% -10.8% 18.3% -100.0% 0.0%   Employees   19 0 0 0 26 26 0 0   Employee growth %   26.7% -100.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   47,566 79,985 86,203 100,642 101,327 111,000 37,714 37,714   Balance sheet change%   16.9% 68.2% 7.8% 16.7% 0.7% 9.5% -66.0% 0.0%   Added value   4,597.0 26,431.0 29,490.0 35,966.0 11,276.0 13,279.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -3,599 -13,129 0 0 4,738 -3,014 -596 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   12.8% 100.0% 100.0% 100.0% 35.2% 31.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.0% 41.4% 35.5% 38.5% 11.2% 11.3% 0.0% 0.0%   ROI %   7.6% 45.3% 35.5% 38.5% 12.0% 13.4% 0.0% 0.0%   ROE %   17.4% 23.7% 31.5% 36.0% 29.4% 24.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   18.6% 100.0% 100.0% 100.0% 29.5% 34.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   382.5% 0.0% 0.0% 0.0% 172.6% 64.9% 0.0% 0.0%   Gearing %   308.7% 0.0% 0.0% 0.0% 190.3% 138.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.7% 0.0% 0.0% 0.0% 5.0% 2.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 0.0 0.0 0.0 1.1 1.2 0.0 0.0   Current Ratio   1.5 0.0 0.0 0.0 1.9 1.9 0.0 0.0   Cash and cash equivalent   9,745.0 0.0 0.0 0.0 34,985.0 44,438.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   12,087.0 0.0 0.0 0.0 45,005.0 49,038.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   242 0 0 0 434 511 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   242 0 0 0 487 511 0 0   EBIT / employee   140 0 0 0 434 453 0 0   Net earnings / employee   74 0 0 0 295 321 0 0